Sernova Welcomes Dr. Bernd Muehlenweg as Evotec's Nominee for Its Board of Directors

Yahoo FinanceApr 22 19:00

Raymond James Initiates Coverage On Sernova With Market Perform Rating, Announces Price Target of $1.5

Raymond James analyst Rahul Sarugaser initiates coverage on Sernova (OTC:SEOVF) with a Market Perform rating and announces Price Target of $1.5.

BenzingaApr 5 01:49

Sernova Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/04/2024 277.41% Raymond James → $1.5 Initiates Coverage On → Market Perform

BenzingaApr 5 01:47

Sernova Reports Anticipated 2024 Milestones

Seeking AlphaJan 29 20:21

Sernova Gets FDA Orphan Drug, Rare Pediatric Designations for Hemophilia A

Seeking AlphaNov 28, 2023 04:06

Sernova Receives Orphan Drug and Rare Pediatric Disease Designations for Its Hemophilia A Program From FDA

LONDON, Ontario and WINDHAM COUNTY, Conn., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in cell therapeutics, today announced the U.S.

GlobeNewswireNov 27, 2023 20:19